Issue Date: February 11, 2008
Alpharma To Sell Bulk Drug Business
The specialty drugmaker Alpharma has signed a deal to sell its active pharmaceutical ingredients (API) business to investment funds managed by 3i, a private equity firm, for $395 million in cash. The business, with 700 employees at plants in Europe and China, makes several fermentation-based APIs and one synthetic API. Alpharma had sales of $139 million in the first nine months of 2007.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society